BRIEF published on 07/11/2024 at 13:05, 1 year 11 months ago CureVac met à jour les dates des procès pour les litiges en matière de brevets contre Pfizer/BioNTech CureVac Contentieux Des Brevets Pfizer/BioNTech Dates Du Procès Mise À Jour Juridique
PRESS RELEASE published on 07/11/2024 at 13:00, 1 year 11 months ago CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech CureVac provides trial date updates for patent litigation against Pfizer/BioNTech in multiple geographies, including the U.S., UK, and Germany BioNTech CureVac Patent Litigation Pfizer Trial Dates
BRIEF published on 07/03/2024 at 08:17, 1 year 11 months ago CureVac Announces Strategic Restructuring to Focus on High-Value mRNA Opportunities Licensing Agreement MRNA Technology Oncology Research Strategic Restructuring Workforce Reduction
BRIEF published on 07/03/2024 at 08:17, 1 year 11 months ago CureVac annonce une restructuration stratégique pour se concentrer sur les opportunités d'ARNm de grande valeur Recherche En Oncologie Technologie ARNm Restructuration Stratégique Réduction Des Effectifs Contrat De Licence
BRIEF published on 07/03/2024 at 08:14, 1 year 11 months ago GSK and CureVac to Restructure Collaboration into New Licensing Agreement Licensing Agreement GSK CureVac MRNA Vaccines
BRIEF published on 07/03/2024 at 08:14, 1 year 11 months ago GSK et CureVac vont restructurer leur collaboration dans le cadre d'un nouvel accord de licence GSK CureVac Vaccins Contrat De Licence ARNm
PRESS RELEASE published on 07/03/2024 at 08:12, 1 year 11 months ago CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities CureVac initiates strategic restructuring to focus on high-value mRNA pipeline opportunities, including workforce reduction and new GSK agreement Oncology Strategic Restructuring CureVac MRNA Pipeline GSK Agreement
PRESS RELEASE published on 07/03/2024 at 08:09, 1 year 11 months ago GSK and CureVac to Restructure Collaboration into New Licensing Agreement GSK and CureVac restructure collaboration into new licensing agreement for mRNA vaccines development, manufacturing, and commercialization globally Licensing Agreement Collaboration GSK MRNA Vaccines CureVac
BRIEF published on 06/24/2024 at 22:10, 1 year 11 months ago CureVac Announces Voting Results of General Meeting Annual General Meeting Voting Results Board Appointments CureVac MRNA
BRIEF published on 06/24/2024 at 22:10, 1 year 11 months ago CureVac annonce les résultats du vote de l'assemblée générale Assemblée Générale Annuelle Nominations Au Conseil CureVac Résultats Du Vote ARNm
Published on 06/20/2026 at 01:00, 2 days 7 hours ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 2 days 8 hours ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 3 days 3 hours ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 3 days 7 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/22/2026 at 08:00, 27 minutes ago Coinsilium Group Limited: ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
Published on 06/22/2026 at 07:30, 57 minutes ago NAGRAVISION Launches NAGRA® Venturi, Intelligence-Led Streaming Security for the AI EraTitle
Published on 06/19/2026 at 19:33, 2 days 12 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 12 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 2 days 13 hours ago Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 2 days 13 hours ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
